InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,048.42
(
-0.46%
)
US TECH 100
17,160.00
(
1.07%
)
Dow Jones
38,085.80
(
-0.98%
)
Brent Oil
88.47
(
0.36%
)
Bitcoin
64,184.50
(
-0.47%
)
Post# of 251605
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jaybird249

Send PM Follow Ignore
Followers 82
Posts 2822
Boards Moderated 0
Alias Born 05/05/2006

jaybird249

Re: None

Tuesday, 06/12/2012 11:46:18 PM

Tuesday, June 12, 2012 11:46:18 PM

Post# of 251605
I think APRI will pull a LCAV like move and run to $5 by July on the FDA meeting Health Canada meetings. With a small float and a drug that has shown remarkable reults, I think it will move fast.

To the Company's knowledge, no product is currently approved to treat FSAD, a persistent or recurring inability to attain, or maintain adequate sexual excitement, causing personal distress. Estimates of the FSAD market size put it on par with erectile dysfunction in males, and possibly larger.,
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up